| Emily Theresa Laver, | |
|
5980 Radio Station Rd, La Plata, MD 20646-3337 | |
| (412) 559-1277 | |
| Not Available |
| Full Name | Emily Theresa Laver |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5980 Radio Station Rd, La Plata, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053885103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14154162 (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Theresa Laver, 219 Arrow Dr, Elizabeth, PA 15037-2603 Ph: (412) 559-1277 | Emily Theresa Laver, 5980 Radio Station Rd, La Plata, MD 20646-3337 Ph: (412) 559-1277 |
News Archive
The American Society for Radiation Oncology continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10.
The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy reports.
Plans by three Catholic hospital systems in Wisconsin to deny admitting privileges to doctors who perform abortions would "be in active violation of federal law," state Attorney General J. B. Van Hollen's Department of Justice said in a court filing last week. Federal law "provides that hospitals accepting federal funds may not discriminate against a physician because that physician has participated in or refused to participate in abortions," the state Justice Department said in its filing in federal court (Ahmed, 8/7).
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
› Verified 2 days ago
Jenae Brendle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-934-7432 | |
Michelle Glasell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-934-7432 | |
Elizabeth Margaret Heinmiller, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-932-6610 | |
Larissa Michelle Vansice, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-932-6610 | |
Erika Suits, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-932-6610 | |
Dr. Mary Boston Downs, SLP,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5980 Radio Station Rd, La Plata, MD 20646 Phone: 301-932-6610 |